Legal Representation
Attorney
Mark E. Tetreault
USPTO Deadlines
Application History
39 eventsDate | Code | Type | Description |
---|---|---|---|
Jan 13, 2025 | GNRT | O | NON-FINAL ACTION E-MAILED |
Jan 13, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Jan 13, 2025 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN |
Nov 18, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Nov 18, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
Nov 18, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED |
Nov 18, 2024 | DPCC | D | DIVISIONAL PROCESSING COMPLETE |
Oct 7, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Oct 7, 2024 | IROA | I | RESPONSE TO ITU OFFICE ACTION ENTERED |
Oct 4, 2024 | INCD | O | ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST |
Sep 20, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Jul 2, 2024 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED |
Jul 2, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Jul 2, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
Jul 2, 2024 | IUAF | S | USE AMENDMENT FILED |
Jul 2, 2024 | DRRR | I | DIVISIONAL REQUEST RECEIVED |
Jul 2, 2024 | EXT1 | S | SOU EXTENSION 1 FILED |
Apr 23, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Mar 4, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Feb 27, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
Feb 7, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Feb 7, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Jan 24, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Jan 24, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
Jan 24, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Jan 24, 2024 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
Jan 24, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
Jan 24, 2024 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
Dec 19, 2023 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY |
Dec 1, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Nov 30, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Nov 30, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Nov 30, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Nov 29, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED |
Nov 29, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Nov 29, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN |
Nov 28, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
Mar 16, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Mar 2, 2023 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Infusion cartridges sold pre-filled with medication for medical use in the field of cardiovascular disease, diabetes, asthma, kidney disease, and cancer; Adhesive overlays in the nature of adhesive medical tape and adhesive bandages for use with infusion pumps and associated devices
First Use Anywhere:
Jun 21, 2024
First Use in Commerce:
Jun 21, 2024
Class 010
Medical devices, namely, infusion and injection devices for administering drugs, and pouches and mounts used therewith; medical devices, namely, infusion pumps for delivering measured amounts of solutions into the bloodstream over time; medical apparatus for monitoring blood analyte levels; implantable subcutaneous drug delivery devices, sold empty in the nature of medical field injectors; on-body medical fluid injectors; chronic disease management devices, in the nature of medical sensors that are implanted or inserted into the human body used to continuously gather human biometric data for monitoring the concentration of analytes in the human body and also including accessories therefor, namely, receivers, sensor housings and sensor insertion devices sold as a unit; medical infusion sets comprised of infusion tubing, infusion needles, needle guards, connectors, attachment clips, and accessories therefor
First Use Anywhere:
Jun 21, 2024
First Use in Commerce:
Jun 21, 2024
Class 041
Educational services, namely, creating and developing web-based and in-person classes, seminars, workshops and programs in the field of managing and living with chronic disease; personalized training and coaching in the use of monitoring devices and infusion pumps in the treatment of chronic disease; training of healthcare providers in chronic disease treatment and the use of infusion pumps and infusion sets
First Use Anywhere:
Jun 21, 2024
First Use in Commerce:
Jun 21, 2024
Class 042
Software-as-a-service (SAAS) featuring software for use in the acquisition, capture, processing, presentation, transmission and storage of medical and physiological data obtained from medical sensors that are implanted or inserted into the human body; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports relating to managing chronic disease, medication and analyte levels; Upgrading of computer software, namely, Software as a Medical Device (SaMD)
First Use Anywhere:
Jun 21, 2024
First Use in Commerce:
Jun 21, 2024
Class 044
Interactive medical monitoring and alert services for reminding infusion pump users of medicinal dosage for medical treatment purposes in the nature of monitoring and managing chronic disease; Providing medical information to infusion pump users in the form of reports in the field of chronic disease management; Providing a website featuring general medical information related to chronic diseases, including advice on treatment options and chronic disease management; Providing online searchable medical databases in the field of chronic disease management for patients, their families, caregivers, and healthcare practitioners; medical consultation services, namely, patient ambassador program to communicate medical information to people with chronic disease
First Use Anywhere:
Jun 21, 2024
First Use in Commerce:
Jun 21, 2024
Additional Information
Pseudo Mark
TWIST
Classification
International Classes
005
010
041
042
044
USPTO Documents
Loading USPTO documents...